These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 3756903)

  • 1. Effect of 5-diazouracil on the catabolism of circulating pyrimidines in rat liver and kidneys.
    Holstege A; Pausch J; Gerok W
    Cancer Res; 1986 Nov; 46(11):5576-81. PubMed ID: 3756903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation.
    Sommadossi JP; Gewirtz DA; Cross DS; Goldman ID; Cano JP; Diasio RB
    Cancer Res; 1985 Jan; 45(1):116-21. PubMed ID: 3965128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and tissue distribution of 2-fluoro-beta-alanine in rats. Potential relevance to toxicity pattern of 5-fluorouracil.
    Zhang RW; Soong SJ; Liu TP; Barnes S; Diasio SB
    Drug Metab Dispos; 1992; 20(1):113-9. PubMed ID: 1346985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of (E)-5-(2-bromovinyl)uracil on the catabolism and antitumor activity of 5-fluorouracil in rats and leukemic mice.
    Desgranges C; Razaka G; De Clercq E; Herdewijn P; Balzarini J; Drouillet F; Bricaud H
    Cancer Res; 1986 Mar; 46(3):1094-101. PubMed ID: 3943086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.
    Heggie GD; Sommadossi JP; Cross DS; Huster WJ; Diasio RB
    Cancer Res; 1987 Apr; 47(8):2203-6. PubMed ID: 3829006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.
    Hull WE; Port RE; Herrmann R; Britsch B; Kunz W
    Cancer Res; 1988 Mar; 48(6):1680-8. PubMed ID: 3125967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of conjugates of 2-fluoro-beta-alanine and bile acids during the metabolism of 5-fluorouracil and 5-fluoro-2-deoxyuridine in the isolated perfused rat liver.
    Sweeny DJ; Barnes S; Diasio RB
    Cancer Res; 1988 Apr; 48(8):2010-4. PubMed ID: 2964897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system.
    Iigo M; Kuretani K; Hoshi A
    Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo effect of 5-ethynyluracil on 5-fluorouracil metabolism determined by 19F nuclear magnetic resonance spectroscopy.
    Adams ER; Leffert JJ; Craig DJ; Spector T; Pizzorno G
    Cancer Res; 1999 Jan; 59(1):122-7. PubMed ID: 9892196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
    Steinke W; Ahr HJ; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vivo studies on the metabolism of pyrimidine nucleosides (author's transl)].
    Dahnke HG; Mosebach KO
    Hoppe Seylers Z Physiol Chem; 1975 Oct; 356(10):1565-74. PubMed ID: 1213673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian variation of 5-fluorouracil catabolism in isolated perfused rat liver.
    Harris BE; Song RL; Soong SJ; Diasio RB
    Cancer Res; 1989 Dec; 49(23):6610-4. PubMed ID: 2819711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate.
    Ho DH; Townsend L; Luna MA; Bodey GP
    Anticancer Res; 1986; 6(4):781-4. PubMed ID: 3752956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraction of 5-fluorouracil by tumor and liver: a noninvasive positron emission tomography study of patients with gastrointestinal cancer.
    Aboagye EO; Saleem A; Cunningham VJ; Osman S; Price PM
    Cancer Res; 2001 Jul; 61(13):4937-41. PubMed ID: 11431319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma clearance and tissue distribution of partially thiolated polycytidylic acid and its degradation products in rodents.
    Kung MP; Ho YK; Lalka D; Bardos TJ
    Cancer Res; 1984 Oct; 44(10):4602-6. PubMed ID: 6467215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.